Suchergebnisse - "Pinato, David J"

PubPharm (15)

1

Efficacy and safety of atezolizumab/bevacizumab in patients with HCC after prior systemic therapy : A global, observational study

enthalten in: Hepatology communications | 2023

von Joerg, V. | Scheiner, B. | D Alessio, A. | +33

2

Response and Outcomes of Maintenance Avelumab After Platinum-Based Chemotherapy (PBC) in Patients With Advanced Urothelial Carcinoma (aUC) : "Real World" Experience

enthalten in: Clinical genitourinary cancer | 2023

von Bakaloudi, D. | Talukder, R. | Lin, G. | +32

3

Clinicopathologic and Genomic Factors Impacting Efficacy of First-Line Chemoimmunotherapy in Advanced NSCLC

enthalten in: Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer | 2023

von Alessi, J. | Elkrief, A. | Ricciuti, B. | +25

CommentIn: J Thorac Oncol. 2023 Jun;18(6):682-685. - PMID 37210177

4

Association of the Time to Immune Checkpoint Inhibitor (ICI) Initiation and Outcomes With Second Line ICI in Patients With Advanced Urothelial Carcinoma

enthalten in: Clinical genitourinary cancer | 2022

von Talukder, R. | Makrakis, D. | Lin, G. | +51

5

Association of prior local therapy and outcomes with programmed-death ligand-1 inhibitors in advanced urothelial cancer

enthalten in: BJU international | 2022

von Makrakis, D. | Talukder, R. | Diamantopoulos, L. | +44

6

Association Between Sites of Metastasis and Outcomes With Immune Checkpoint Inhibitors in Advanced Urothelial Carcinoma

enthalten in: Clinical genitourinary cancer | 2022

von Makrakis, D. | Talukder, R. | Lin, G. | +49

7

Response and Outcomes to Immune Checkpoint Inhibitors in Advanced Urothelial Cancer Based on Prior Intravesical Bacillus Calmette-Guerin

enthalten in: Clinical genitourinary cancer | 2022

von Talukder, R. | Makrakis, D. | Diamantopoulos, L. | +44

8

Immunotherapies for hepatocellular carcinoma

enthalten in: Nature reviews. Clinical oncology | 2022

von Llovet, J. | Castet, F. | Heikenwalder, M. | +6

9

Clinical Outcomes and Toxic Effects of Single-Agent Immune Checkpoint Inhibitors Among Patients Aged 80 Years or Older With Cancer : A Multicenter International Cohort Study

enthalten in: JAMA oncology | 2021

von Nebhan, C. | Cortellini, A. | Ma, W. | +42

10

Upregulation of C/EBPα Inhibits Suppressive Activity of Myeloid Cells and Potentiates Antitumor Response in Mice and Patients with Cancer

enthalten in: Clinical cancer research : an official journal of the American Association for Cancer Research | 2021

von Hashimoto, A. | Sarker, D. | Reebye, V. | +28